Kasvu Therapeutics develops first-in-class small molecule neuroplastogens for treating diseases with altered neuronal connectivity. Their treatments are potent, rapid-acting, and long-lasting without causing hallucinations.
Total Funding
$10M+
Total Rounds
1
First Raise
Sep 24, 2026
Latest Raise
Sep 24, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/24/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free